Mrns stock price.

MRNS stock earns a Strong Buy consensus based on nine Buys, one Hold, and zero Sells assigned by analysts in the past three months. MRNS stock’s one-year average price target is $19.44, implying a sizable 96.6% gain from here, with the lowest price target at $9.00 per share and the highest at $27.00.

Mrns stock price. Things To Know About Mrns stock price.

Fulcrum Therapeutics Inc. 9.64. +0.24. +2.55%. Get Marinus Pharmaceuticals Inc (MRNS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Leverage Shares Public Limited Company Ls -3x Short Moderna Etp is listed on the London Stock Exchange trading with ticker code MRNS.L. It has a market capitalisation of -, with approximately 0.00 ...Open price. $9.98. Open price $9.98. Volume. 266.39K. Volume 266.39K. 52 Week high. $11.26. 52 Week high $11.26. 52 Week low. $5.57. 52 Week low $5.57. MRNS News. Yahoo Finance 2d. ... Sign up for a Robinhood brokerage account to buy or sell MRNS stock and options commission-free. Other fees may apply.SEC Filings. Find the latest Marinus Pharmaceuticals, Inc. (MRNS) stock quote, history, news and other vital information to help you with your stock trading and investing.

Marinus Pharmaceuticals Inc (MRNS) stock is trading at $10.01 as of 12:41 PM on Thursday, Jan 25, a rise of $0.15, or 1.52% from the previous closing price of $9.86. The stock has traded between $9.93 and $10.24 so far today. Volume today is below average. So far 193,281 shares have traded compared to average volume of 488,849 …Alnylam Pharmaceuticals Inc. 168.60. -3.58. -2.08%. Get Moderna Inc (MRNA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.MRNS Stock Summary. MRNS's price/sales ratio is 18.37; that's higher than the P/S ratio of 93.99% of US stocks. Over the past twelve months, MRNS has reported earnings growth of 3,237.93%, putting it ahead of 99.7% of US stocks in our set. As for revenue growth, note that MRNS's revenue has grown 56.08% over the past 12 months; that beats the ...

Marinus Pharmaceuticals, Inc. Common Stock (MRNS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

Summary of all time highs, changes and price drops for Marinus Pharmaceuticals; Historical stock prices; Current Share Price: US$9.77: 52 Week High: …Their MRNS share price targets range from $9.00 to $28.00. On average, they anticipate the company's stock price to reach $20.44 in the next year. This suggests a …Marinus Pharmaceuticals Inc (MRNS) stock is trading at $9.63 as of 12:48 PM on Tuesday, Jan 16, a loss of -$0.17, or -1.73% from the previous closing price of $9.80. The stock has traded between $9.37 and $9.73 so far today. Volume today is …Feb 14, 2024 · The Marinus Pharmaceuticals stock price gained 1.11% on the last trading day (Wednesday, 14th Feb 2024), rising from $9.90 to $10.01. During the last trading day the stock fluctuated 2.31% from a day low at $9.94 to a day high of $10.17. The price has risen in 6 of the last 10 days and is up by 2.77% over the past 2 weeks. Thinking about buying or selling stock in MRNS? See the latest Marinus Pharmaceuticals Inc. (MRNS) stock analysis, price, forecast, news and more.

The Marinus Pharmaceuticals stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of MRNS stock is predicted to rise by 2.24% tomorrow and gain 10.19% in the next 7 days.

Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A. Style Scorecard.

Looking to buy Marinus Pharmaceuticals Stock? View today's MRNS stock price, trade commission-free, and discuss MRNS stock updates with the investor community. Find the latest news headlines from Marinus Pharmaceuticals, Inc. Common Stock (MRNS) at Nasdaq.com.Marinus' (MRNS) shares rise as it provides revenue and cash guidance for third-quarter 2023. The company also updates on the progress of its pipeline candidates targeting major central nervous system disorders. Find the latest Marinus Pharmaceuticals, Inc. (MRNS) stock quote, history, news and other vital information to help you with your stock ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...Find the latest Marinus Pharmaceuticals, Inc. MRNS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.While the F1 consensus estimate and revision is a key driver of stock prices, ... Should You Add Marinus (MRNS) Stock to Your Portfolio Now? 01/22/24-8:56AM EST Zacks MRNS: ...

Our common stock is listed on the Nasdaq Global Market under the symbol “MRNS.” Holders of Record. As of March 18, 2022, there were approximately 15 holders ...It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Shares of COVID-19 vaccine maker Moderna MRNA rose 13.1% on Jan 2, after analysts at Oppenheimer recently upgraded the stock’s recommendation to Outperform, with a price target of $142 per share.22.41%. Get the latest Marinus Pharmaceuticals Inc (MRNS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment... The Marinus Pharmaceuticals stock price forecast for the next 30 days is a projection based on the positive/negative trends in the past 30 days. Based on the current trend the price of MRNS stock is predicted to rise by 2.24% tomorrow and gain 10.19% in the next 7 days. MRNS, Marinus Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlinesApr 18, 2023 · Marinus Pharmaceuticals MRNS shares soared 8.4% in the last trading session to close at $8.01. The move was backed by solid volume with far more shares changing hands than in a normal session ...

MRNS : 9.74 (-2.50%) Marinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions …MRNS support price is $9.58 and resistance is $10.22 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNS stock will trade within this expected range on the day.

Marinus Pharmaceuticals Stock (NASDAQ:MRNS): ... The pharmaceutical company’s stock is currently trading 87% below its all-time-high closing price of $77.52 on August 4, 2015.Apr 18, 2023 · Marinus Pharmaceuticals MRNS shares soared 8.4% in the last trading session to close at $8.01. The move was backed by solid volume with far more shares changing hands than in a normal session ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Aug-29-22 04:01PM. Marinus Pharmaceuticals Announces Closing of Sale of Priority Review Voucher for $110 Million. (Business Wire) Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a ... Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 19.74% and 18.38%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?MRNS Stock Price 1D 5D 1M 6M YTD 1Y 5Y 10Y MAX Basic +43.32% Feb 2024 Dec 2023 Oct 2023 Aug 2023 Jun 2023 Apr 2023 4 6 8 10 12 52 Week RangeStock Price Forecast. The 8 analysts with 12-month price forecasts for MRNS stock have an average target of 20.75, with a low estimate of 13 and a high estimate of 28. The average target predicts an increase of 112.38% from the current stock price of 9.77.

Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...

Jan 26, 2024 · Marinus Pharmaceuticals 's market cap is calculated by multiplying MRNS's current stock price of $10.02 by MRNS's total outstanding shares of 54,573,581. Compare with up to 5 Stocks. On Wednesday morning 02/21/2024 the Moderna Inc share started trading at the price of $86.15. Compared to the closing price on Tuesday 02/20/2024 on NAS of $86.99 ...Get YieldMax MRNA Option Income Strategy ETF (MRNY.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and …Research Marinus Pharmaceuticals' (BMV:MRNS *) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.by Zacks Equity Research Published on January 17,2024. The mean of analysts' price targets for Marinus Pharmaceuticals (MRNS) points to an 113% upside in the stock. While this highly sought-after ...The average Marinus Pharmaceuticals stock price prediction forecasts a potential upside of 164.68% from the current MRNS share price of $9.54. What is MRNS's forecast return on equity (ROE) for 2024-2027?View the latest Marinus Pharmaceuticals Inc. (MRNS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Marinus Pharmaceuticals higher as Truist and JMP raises price target after FDA approved ZTALMY Mar. 22, 2022 12:36 PM ET Marinus Pharmaceuticals, Inc. (MRNS) Stock By: Niloofer Shaikh , SA News Editor

Marinus Pharmaceuticals Inc stock price live 10.12, this page displays NASDAQ MRNS stock exchange data. View the MRNS premarket stock price ahead of the market session or assess the after hours quote.Feb 9, 2024 · Stock analysis for Marinus Pharmaceuticals Inc (MRNS:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Marinus Pharmaceuticals, Inc. Stock price Mexican S.E. Equities MRNS * US56854Q2003 Pharmaceuticals End-of-day quote Mexican S.E. Other stock markets. 06:00:00 2023-12-05 pm EST 5-day change ...View the latest MRNS earnings date, analysts forecasts, earnings history, and conference call transcripts. Skip to main content. S&P 500 5,088.80. DOW 39,131.53. QQQ 436.78. ... Stock Ideas and Recommendations. Get daily stock ideas from top-performing Wall Street analysts.Instagram:https://instagram. everton vs chelseajimi hendrix all along the watchtowermonopoly go link for trading cardsjulius novachrono Marinus Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Marinus Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Marinus Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Marinus Pharmaceuticals's MRNS shares and …MRNA Stock 12 Months Forecast. $131.38. (48.67% Upside) Based on 13 Wall Street analysts offering 12 month price targets for Moderna in the last 3 months. The average price target is $131.38 with a high forecast of $310.00 and a low forecast of $55.00. The average price target represents a 48.67% change from the last price of $88.37. firefox descargarmary kay consultants near me Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest... charger super bee Aug-29-22 04:01PM. Marinus Pharmaceuticals Announces Closing of Sale of Priority Review Voucher for $110 Million. (Business Wire) Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a ... Find the latest Marinus Pharmaceuticals, Inc. (MRNS) stock quote, history, news and other vital information to help you with your stock trading and investing.TradingView India. View live Marinus Pharmaceuticals, Inc. chart to track its stock's price action. Find market predictions, MRNS financials and market news.